PharmiWeb48m
Global Pediatric Heart Valve Repair and Replacement Industry Poised for Remarkable Growth Reaching USD 4,490.5 Million by 2034 at a CAGR of 2.7%
Pediatric Heart Valve Repair and Replacement IndustryThe global pediatric heart valve repair and replacement industry is on a promising growth trajectory, with recent analysis projecting a substantial ...
Medscape11h
Ross Procedure Making a Comeback in Aortic Valve Disease
New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.
Healio16h
CABG plus surgical AVR may suit certain older patients with aortic stenosis, CAD
CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...
Pharmabiz22h
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis
Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hrs [IST] ...